Cardiac biosensors stand at the forefront of transformative healthcare technologies, revolutionizing the landscape of cardiovascular diagnostics and monitoring. These state-of-the-art biosensors employ sophisticated sensing mechanisms to identify specific biomarkers or physiological signals associated with cardiac health. The real-time and precise data provided by cardiac biosensors enable healthcare practitioners to make informed decisions promptly, ushering in a new era of personalized and responsive patient care. These biosensors are instrumental in the early identification, continuous monitoring, and effective management of cardiovascular conditions, significantly enhancing patient outcomes. As the field of biosensing technology evolves through ongoing research and development, the incorporation of cardiac biosensors promises to redefine the standards of cardiovascular healthcare, bringing forth a future where proactive and personalized cardiac monitoring becomes integral to the standard of care.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States